Peter R. Byron

5.4k total citations · 1 hit paper
99 papers, 3.9k citations indexed

About

Peter R. Byron is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Biomedical Engineering. According to data from OpenAlex, Peter R. Byron has authored 99 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 14 papers in Pharmaceutical Science and 14 papers in Biomedical Engineering. Recurrent topics in Peter R. Byron's work include Inhalation and Respiratory Drug Delivery (66 papers), Drug Solubulity and Delivery Systems (11 papers) and Asthma and respiratory diseases (11 papers). Peter R. Byron is often cited by papers focused on Inhalation and Respiratory Drug Delivery (66 papers), Drug Solubulity and Delivery Systems (11 papers) and Asthma and respiratory diseases (11 papers). Peter R. Byron collaborates with scholars based in United States, United Kingdom and Czechia. Peter R. Byron's co-authors include John S. Patton, Michael Hindle, P. Worth Longest, Richard N. Dalby, Renishkumar Delvadia, Joanne Peart, Chris Vervaet, Masahiro Sakagami, Elaine M. Phillips and Ralph W. Niven and has published in prestigious journals such as Nature Reviews Drug Discovery, Advanced Drug Delivery Reviews and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Peter R. Byron

98 papers receiving 3.7k citations

Hit Papers

Inhaling medicines: delivering drugs to the body through ... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Byron United States 32 2.9k 945 562 549 508 99 3.9k
Jeffry G. Weers United States 32 2.2k 0.7× 702 0.7× 519 0.9× 685 1.2× 262 0.5× 78 3.6k
Igor Gonda Australia 37 2.9k 1.0× 693 0.7× 767 1.4× 322 0.6× 264 0.5× 141 4.1k
Michael Hindle United States 40 3.5k 1.2× 408 0.4× 649 1.2× 661 1.2× 1.1k 2.1× 133 4.2k
Heidi M. Mansour United States 36 2.1k 0.7× 1.0k 1.1× 294 0.5× 601 1.1× 282 0.6× 123 3.7k
Daniela Traini Australia 44 4.1k 1.4× 2.2k 2.3× 666 1.2× 1.2k 2.2× 701 1.4× 278 6.8k
Christopher Marriott United Kingdom 26 1.5k 0.5× 830 0.9× 185 0.3× 772 1.4× 340 0.7× 80 2.4k
Anne Marie Healy Ireland 42 1.3k 0.5× 2.2k 2.3× 244 0.4× 1.0k 1.9× 251 0.5× 148 4.9k
Albert H.L. Chow Hong Kong 33 896 0.3× 1.4k 1.5× 303 0.5× 735 1.3× 217 0.4× 76 4.4k
John N. Staniforth United Kingdom 26 1.1k 0.4× 889 0.9× 101 0.2× 635 1.2× 350 0.7× 94 2.3k
Francesca Buttini Italy 29 1.5k 0.5× 1.2k 1.3× 311 0.6× 471 0.9× 147 0.3× 97 2.7k

Countries citing papers authored by Peter R. Byron

Since Specialization
Citations

This map shows the geographic impact of Peter R. Byron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Byron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Byron more than expected).

Fields of papers citing papers by Peter R. Byron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Byron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Byron. The network helps show where Peter R. Byron may publish in the future.

Co-authorship network of co-authors of Peter R. Byron

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Byron. A scholar is included among the top collaborators of Peter R. Byron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Byron. Peter R. Byron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hindle, Michael, et al.. (2017). In Vitro Tests for Aerosol Deposition. V: Using Realistic Testing to Estimate Variations in Aerosol Properties at the Trachea. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(5). 339–348. 13 indexed citations
3.
Delvadia, Renishkumar, et al.. (2015). In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(2). 196–206. 46 indexed citations
4.
Delvadia, Renishkumar, Michael Hindle, P. Worth Longest, & Peter R. Byron. (2012). In Vitro Tests for Aerosol Deposition II: IVIVCs for Different Dry Powder Inhalers in Normal Adults. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26(3). 138–144. 82 indexed citations
5.
Delvadia, Renishkumar, P. Worth Longest, & Peter R. Byron. (2011). In Vitro Tests for Aerosol Deposition. I: Scaling a Physical Model of the Upper Airways to Predict Drug Deposition Variation in Normal Humans. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(1). 32–40. 102 indexed citations
6.
Peart, Joanne, et al.. (2008). Calibration of the Modified Electrical Low-Pressure Impactor (ELPI) for Use with Pressurized Pharmaceutical Aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 22(1). 55–66. 12 indexed citations
7.
Longest, P. Worth, et al.. (2007). Numerical Simulations of Capillary Aerosol Generation: CFD Model Development and Comparisons with Experimental Data. Aerosol Science and Technology. 41(10). 952–973. 85 indexed citations
8.
Sakagami, Masahiro & Peter R. Byron. (2005). Respirable Microspheres for Inhalation. Clinical Pharmacokinetics. 44(3). 263–277. 26 indexed citations
9.
Sakagami, Masahiro, et al.. (2004). Aerodynamic sizing of metered dose inhalers: An evaluation of the andersen and next generation pharmaceutical impactors and their USP methods. Journal of Pharmaceutical Sciences. 93(7). 1828–1837. 28 indexed citations
10.
Byron, Peter R.. (2004). Drug Delivery Devices: Issues in Drug Development. Proceedings of the American Thoracic Society. 1(4). 321–328. 54 indexed citations
11.
Hindle, Michael, et al.. (2003). Investigation of a Novel Condensation Aerosol Generator: Solute and Solvent Effects. Aerosol Science and Technology. 37(8). 672–681. 25 indexed citations
12.
Sakagami, Masahiro, Peter R. Byron, Jürgen Venitz, & František Rypáček. (2002). Solute disposition in the rat lung in vivo and in vitro: Determining regional absorption kinetics in the presence of mucociliary escalator. Journal of Pharmaceutical Sciences. 91(2). 594–604. 22 indexed citations
14.
Byron, Peter R., Joanne Peart, & John N. Staniforth. (1997). Aerosol Electrostatics I: Properties of Fine Powders Before and After Aerosolization by Dry Powder Inhalers. Pharmaceutical Research. 14(6). 698–705. 84 indexed citations
16.
Byron, Peter R. & John S. Patton. (1994). Drug Delivery via the Respiratory Tract. Journal of Aerosol Medicine. 7(1). 49–75. 169 indexed citations
17.
Byron, Peter R.. (1993). DRUG DELIVERY VIA THE RESPIRATORY TRACT. Journal of Aerosol Medicine. 6(supplement_6). 51–55. 7 indexed citations
18.
Phillips, Elaine M., et al.. (1990). Optimized Inhalation Aerosols. II. Inertial Testing Methods for Particle Size Analysis of Pressurized Inhalers. Pharmaceutical Research. 7(12). 1228–1233. 23 indexed citations
19.
Dalby, Richard N. & Peter R. Byron. (1988). Comparison of Output Particle Size Distributions from Pressurized Aerosols Formulated as Solutions or Suspensions. Pharmaceutical Research. 5(1). 36–39. 46 indexed citations
20.
Byron, Peter R. & Ralph W. Niven. (1988). A novel dosing method for drug administration to the airways of the isolated perfused rat lung. Journal of Pharmaceutical Sciences. 77(8). 693–695. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026